ASCVD (Atherosclerotic Cardiovascular Disease) 2013 Risk Calculator from AHA/ACC
ورودیهای بالینی بیمار
حداقل ۴۰ — حداکثر ۷۹ • واحد: years
حداقل ۱۳۰ — حداکثر ۳۲۰ • واحد: mg/dL
حداقل ۲۰ — حداکثر ۱۰۰ • واحد: mg/dL
حداقل ۹۰ — حداکثر ۲۰۰ • واحد: mmHg
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Low Risk0–5
- Borderline Risk5–7.5
- Intermediate Risk7.5–20
- High Risk20–100
The ASCVD (Atherosclerotic Cardiovascular Disease) 2013 Risk Calculator from AHA/ACC calculates stratifying cardiovascular risk, predicting thromboembolic events, or guiding therapeutic interventions. Key inputs include age. Scores guide initiating guideline-directed medical therapy, antithrombotic or anticoagulant regimens, or urgent coronary angiography. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Estimates the 10-year risk of atherosclerotic cardiovascular disease (heart attack, stroke, or death due to coronary heart disease or stroke) using the Pooled Cohort Equations. For patients 40-79 years old with no history of ASCVD.
Clinical Indication
The ASCVD (Atherosclerotic Cardiovascular Disease) 2013 Risk Calculator from AHA/ACC is indicated for bedside clinical practice to support Estimates the 10-year risk of atherosclerotic cardiovascular disease (heart attack, stroke, or death due to coronary heart disease or stroke) using the Pooled Cohort Equations. For patients 40-79 years old with no history of ASCVD.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Adult patients presenting with suspected or established coronary artery disease, cardiac arrhythmias, congestive heart failure, or valvular heart defects. Clinical application is indicated across Emergency department, cardiac care unit (CCU), cardiac catheterization laboratory, and outpatient cardiology clinics.
Limitations & Contraindications
In hemodynamically unstable cardiogenic shock, cardiac arrest, or refractory acute coronary syndromes, immediate resuscitation and coronary angiography supersede scoring. Clinical exclusion: Not applicable to patients with prior ASCVD, LDL-C ≥190 mg/dL, or age outside 40-79 years.
Clinical Pearls & Action Plan
Continuous 12-lead ECG monitoring, serial cardiac troponin measurements, and echocardiographic evaluation align with ESC/ACC/AHA clinical practice guidelines. Guideline pearl: USPSTF recommends statin therapy for ages 40-75 with ≥1 CVD risk factor and 10-year risk ≥10%.
10-year ASCVD risk = 1 - S₀(t)^exp(Xβ - mean Xβ), where S₀(t) is the baseline survival, Xβ is the sum of coefficient × value for each risk factor, with race- and sex-specific coefficients
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| age | integer | Yes | Patient's age in years (must be between 40 and 79)(years) |
| sex | string | Yes | Patient's biological sex |
| race | string | Yes | Patient's race (White or African American) |
| total_cholesterol | float | Yes | Total cholesterol level(mg/dL) |
| hdl_cholesterol | float | Yes | HDL cholesterol level(mg/dL) |
| systolic_bp | integer | Yes | Systolic blood pressure(mmHg) |
| bp_treatment | boolean | Yes | Currently on blood pressure lowering medication |
| diabetes | boolean | Yes | History of diabetes mellitus |
| smoker | boolean | Yes | Current smoker (cigarettes, cigars, or pipe) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–5 | Low Risk | <5% 10-year risk |
| 5–7.5 | Borderline Risk | 5% to <7.5% 10-year risk |
| 7.5–20 | Intermediate Risk | 7.5% to <20% 10-year risk |
| 20–100 | High Risk | ≥20% 10-year risk |
Evidence-Based References (EBM)
- Goff DC Jr, Lloyd-Jones DM, Bennett G, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014 Jun 24;129(25 Suppl 2):S49-73.
- Stone NJ, Robinson JG, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014 Jun 24;129(25 Suppl 2):S1-45.
- Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019 Sep 10;140(11):e596-e646.